PUFAS

/ SCIENCE / By
  1. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats
  2. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients
  3. Advances in our understanding of oxylipins derived from dietary PUFAs
  4. N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of early-life stress on the gut microbiota
  5. Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western …
  6. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children
  7. Potential roles of n-3 PUFAs during skeletal muscle growth and regeneration
  8. Efficacy of omega-3 PUFAs in depression: a meta-analysis
  9. Thraustochytrid marine protists: production of PUFAs and other emerging technologies
  10. Does supplementation with omega-3 PUFAs add to the prevention of cardiovascular disease?
  11. Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes
  12. Cox-2 expression, PGE2 and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice
  13. Dietary n-3 PUFAs deficiency increases vulnerability to inflammation-induced spatial memory impairment
  14. PUFAs: structures, metabolism and functions
  15. PUFAs in fish: extraction, fractionation, importance in health
  16. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system
  17. Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein
  18. Omega− 3 Polyunsaturated Fatty Acids (PUFAs): Emerging Plant and Microbial Sources, Oxidative Stability, Bioavailability, and Health Benefits—A Review
  19. The anti-inflammatory and antioxidant properties of n-3 PUFAs: Their role in cardiovascular protection
  20. Advances in microencapsulation of polyunsaturated fatty acids (PUFAs)-rich plant oils using complex coacervation: A review
  21. Effects of fish n-3 PUFAs on intestinal microbiota and immune system
  22. Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil
  23. Microbial sources of polyunsaturated fatty acids (PUFAs) and the prospect of organic residues and wastes as growth media for PUFA-producing microorganisms
  24. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
  25. n-3 PUFAs modulate T-cell activation via protein kinase C-α and-ε and the NF-κB signaling pathway
  26. A novel anti-inflammatory role of omega-3 PUFAs in prevention and treatment of atherosclerosis and vascular cognitive impairment and dementia
  27. Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca: a randomized double-blind clinical trial
  28. Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders
  29. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with …
  30. G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway
  31. Do ω-3 PUFAs affect insulin resistance in a sex-specific manner? A systematic review and meta-analysis of randomized controlled trials
  32. Intakes of long-chain omega-3 (n− 3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study
  33. Long-chain n− 3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
  34. PUFAs, bone mineral density, and fragility fracture: findings from human studies
  35. The Physiological Effect of n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Intake and Exercise on Hemorheology, Microvascular Function, and Physical …
  36. Omega-3 PUFAs lower the propensity for arachidonic acid cascade overreactions
  37. ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation
  38. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and …
  39. Omega-3 index and anti-arrhythmic potential of omega-3 PUFAs
  40. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ
  41. The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions
  42. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE 2 induced ERK-1 and -2 and HIF-1α induction pathway
  43. Fish oil LC-PUFAs do not affect blood coagulation parameters and bleeding manifestations: Analysis of 8 clinical studies with selected patient groups on …
  44. Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation
  45. Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation
  46. The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs
  47. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
  48. Microalgae n-3 PUFAs Production and Use in Food and Feed Industries
  49. Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies
  50. Enhanced physicochemical stability of ω-3 PUFAs concentrates-loaded nanoliposomes decorated by chitosan/gelatin blend coatings
  51. N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro
  52. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases
  53. Dietary polyunsaturated fatty acids (PUFAs): Uses and potential health benefits
  54. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain
  55. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2
  56. Elevation of n-3/n-6 PUFAs ratio suppresses mTORC1 and prevents colorectal carcinogenesis associated with APC mutation
  57. Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndrome
  58. Tropical marine macroalgae as potential sources of nutritionally important PUFAs
  59. Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries
  60. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
  61. Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease
  62. Current evidence and future perspectives on n− 3 PUFAs
  63. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins—the Jerusalem Nutrition Study: high MUFAs vs high PUFAs
  64. Manipulation of omega‐3 PUFAs in lamb: Phenotypic and genotypic views
  65. What is the impact of n-3 PUFAs on inflammation markers in type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized …
  66. ω‐3 PUFAs Alleviate High‐Fat Diet–Induced Circadian Intestinal Microbes Dysbiosis
  67. Dietary intake of n-3 PUFAs modifies the absorption, distribution and bioavailability of fatty acids in the mouse gastrointestinal tract
  68. Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature …
  69. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane
  70. Cardioprotective effects of ω-3 PUFAs in chronic kidney disease
  71. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to …
  72. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells
  73. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress
  74. N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway
  75. Effect of omega-3 PUFAs supplementation with lifestyle modification on anthropometric indices and Vo2 max in overweight women
  76. n–3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral …
  77. n-3 PUFAs and cardiovascular disease prevention
  78. Cellular production of n-3 PUFAs and reduction of n-6–to–n-3 ratios in the pancreatic β-cells and islets enhance insulin secretion and confer protection against …
  79. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation
  80. Minerals, PUFAs and antioxidant properties of some tropical seaweeds from Saurashtra coast of India
  81. Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains
  82. Lowering the n-6/n-3 PUFAs ratio inhibits the formation of THP-1 macrophage-derived foam cell
  83. Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1
  84. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype
  85. Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial
  86. PPARγ mediates a direct antiangiogenic effect of ω3-PUFAs in proliferative retinopathy
  87. Efficacy of polyunsaturated fatty acids (PUFAs) on impulsive behaviours and aggressiveness in psychiatric disorders
  88. Effect of low doses of long-chain n− 3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial
  89. Plant‐ and Fish‐Derived n‐3 PUFAs Suppress Citrobacter Rodentium–Induced Colonic Inflammation
  90. Metabolic syndrome: effects of n‐3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity
  91. ELOVL4 protein preferentially elongates 20: 5n3 to very long chain PUFAs over 20: 4n6 and 22: 6n3
  92. Enriching diet with n-3 PUFAs to help prevent cardiovascular diseases in healthy adults: Results from clinical trials
  93. n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse model
  94. n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity [S]
  95. The anticancer effects of Vitamin D and omega-3 PUFAs in combination via cod-liver oil: one plus one may equal more than two
  96. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase …
  97. Recent evidence on the role of dietary PUFAs in cancer development and prevention
  98. Neurite outgrowth stimulation by n-3 and n-6 PUFAs of phospholipids in apoE-containing lipoproteins secreted from glial cells
  99. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs
  100. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction
  101. Drosophila lacks C20 and C22 PUFAs
  102. Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild …
  103. Nutritional and sensory properties of dry fermented sausages enriched with n− 3 PUFAs
  104. Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo
  105. N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity
  106. Fish as source of n-3 polyunsaturated fatty acids (PUFAs), which one is better-farmed or wild
  107. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) in cardiovascular diseases (CVDs) and depression: the missing link?
  108. N-3 PUFAs Protect against Aortic Inflammation and Oxidative Stress in Angiotensin II-Infused Apolipoprotein E-/- Mice
  109. N-3 PUFAs inhibited hepatic ER stress induced by feeding of a high-saturated fat diet accompanied by the expression LOX-1
  110. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type …
  111. Novel anti-inflammatory ω-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus
  112. n-3 PUFAs inhibit TGFβ1-induced profibrogenic gene expression by ameliorating the repression of PPARγ in hepatic stellate cells
  113. EPA: DHA 6: 1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery …
  114. Relationship between the effect of polyunsaturated fatty acids (PUFAs) on brain plasticity and the improvement on cognition and behavior in individuals with autism …
  115. The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy
  116. Effects of n‐3 PUFAs on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance
  117. The effect of n-3 PUFAs on circulating adiponectin and leptin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled …
  118. Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart
  119. Higher plasma phospholipid n–3 PUFAs, but lower n–6 PUFAs, are associated with lower pulse wave velocity among older adults
  120. Reconstitution of EPA and DHA biosynthesis in Arabidopsis: Iterative metabolic engineering for the synthesis of n− 3 LC-PUFAs in transgenic plants
  121. Combined buckwheat d-fagomine and fish omega-3 PUFAs stabilize the populations of gut Prevotella and Bacteroides while reducing weight gain in rats
  122. Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy
  123. The role of polyunsaturated fatty acids (n-3 PUFAs) on the pancreatic β-cells and insulin action
  124. N− 3 PUFAs modulate global gene expression profile in cultured rat cardiomyocytes. Implications in cardiac hypertrophy and heart failure
  125. Maternal dietary PUFAs intake and human milk content relationships during the first month of lactation
  126. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C [S]
  127. n–3 PUFAs Reduce T-Helper 17 Cell Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Mouse Splenic CD4+ T Cells
  128. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A …
  129. Diversity of fatty acid composition of symbiotic dinoflagellates in corals: evidence for the transfer of host PUFAs to the symbionts
  130. Comparison of diatoms and dinoflagellates from different habitats as sources of PUFAs
  131. Alternative lipids to usual ω6 PUFAs: γ‐Linolenic acid, α‐linolenic acid, stearidonic acid, EPA, etc
  132. Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
  133. Analysis of Δ12-fatty acid desaturase function revealed that two distinct pathways are active for the synthesis of PUFAs in T. aureum ATCC 34304
  134. Lowered ω-3 PUFAs are related to major depression, but not to somatization syndrome
  135. Dietary intake of PUFAs and colorectal polyp risk
  136. Impulsivity-based thrifty eating phenotype and the protective role of n-3 PUFAs intake in adolescents
  137. Differential composition of DHA and very-long-chain PUFAs in rod and cone photoreceptors
  138. n− 3 PUFAs in cardiovascular disease
  139. Alterations in the intestinal assimilation of oxidized PUFAs are ameliorated by a polyphenol-rich grape seed extract in an in vitro model and Caco-2 cells
  140. Role of omega-3 PUFAs in neurobiological health
  141. Development of an LC-ESI (-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3-and n6-PUFAs
  142. Transgenic n-3 PUFAs enrichment leads to weight loss via modulating neuropeptides in hypothalamus
  143. Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects
  144. Role of oxylipins generated from dietary PUFAs in the modulation of endothelial cell function
  145. Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice
  146. Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system
  147. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment
  148. Maternal dietary intake of fish and PUFAs and child neurodevelopment at 6 months and 1 year of age: a nationwide birth cohort—the Japan Environment and …
  149. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with …
  150. Cytokine dysregulation in MECP2-and CDKL5-related Rett syndrome: relationships with aberrant redox homeostasis, inflammation, and ω-3 PUFAs
  151. Plasma phospholipid PUFAs are associated with greater muscle and knee extension strength but not with changes in muscle parameters in older adults
  152. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in≥ 75 years old patients: A randomized multicenter …
  153. Higher intake of PUFAs is associated with lower total and visceral adiposity and higher lean mass in a racially diverse sample of children
  154. Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport
  155. A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder
  156. A potential role of PUFAs and COXIBs in cancer chemoprevention
  157. Endogenous n-3 PUFAs attenuated olfactory bulbectomy-induced behavioral and metabolomic abnormalities in Fat-1 mice
  158. Biological activities of non-enzymatic oxygenated metabolites of polyunsaturated fatty acids (NEO-PUFAs) derived from EPA and DHA: New anti-arrhythmic …
  159. Pseudomonas aeruginosa responds to exogenous polyunsaturated fatty acids (PUFAs) by modifying phospholipid composition, membrane permeability, and …
  160. Formulation of mayonnaises containing PUFAs by the addition of microencapsulated chia seeds, pumpkin seeds and baru oils
  161. Fish-Oil–Derived n–3 PUFAs Reduce Inflammatory and Chemotactic Adipokine-Mediated Cross-talk between Co-cultured Murine Splenic CD8+ T Cells and …
  162. The Role of Nutraceuticals in Osteoarthritis Prevention and Treatment: Focus on n-3 PUFAs
  163. Anti-diabetic activity of PUFAs-rich extracts of Chlorella pyrenoidosa and Spirulina platensis in rats
  164. The anti-arrhythmic effects of n− 3 PUFAs
  165. Dietary n-3 PUFAs improve fresh and post-thaw semen quality in Holstein bulls via alteration of sperm fatty acid composition
  166. Myogenic differentiation and lipid-raft composition of L6 skeletal muscle cells are modulated by PUFAs
  167. The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents [S]
  168. Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes
  169. Re-assessing the mechanism of action of n− 3 PUFAs
  170. Red blood cell PUFAs reflect the phospholipid PUFA composition of major organs
  171. Supercritical fluid extraction from microalgae with high content of LC-PUFAs. A case of study: Sc-CO2 oil extraction from Schizochytrium sp
  172. … ω-3 polyunsaturated Fatty Acids (PUFAs) in an animal feeding study?—Effects of the temperature, oxygen level, and antioxidant on oxidative stability of ω-3 PUFAs in …
  173. Dietary long-chain n-3 PUFAs mitigate CD4+ T cell/adipocyte inflammatory interactions in co-culture models of obese adipose tissue
  174. n3 PUFAs Reduce Mouse CD4+ T-Cell Ex Vivo Polarization into Th17 Cells
  175. Prevention of cardiovascular diseases and highly concentrated n-3 polyunsaturated fatty acids (PUFAs)
  176. Macrophage fatty acid metabolism and atherosclerosis: the rise of PUFAs
  177. Impact of environment conditions on physicochemical characteristics of ovalbumin heat-induced nanoparticles and on their ability to bind PUFAs
  178. The regulation of leptin, leptin receptor and pro-opiomelanocortin expression by N-3 PUFAs in diet-induced obese mice is not related to the methylation of …
  179. Clinical trials of PUFAs in depression: State of the art
  180. Effects of Different n6/n3 PUFAs Dietary Ratio on Cardiac Diabetic Neuropathy
  181. In-depth study of the interaction, sensitivity, and gating modulation by PUFAs on K+ channels; interaction and new targets
  182. Habitual consumption of long-chain n–3 PUFAs and fish attenuates genetically associated long-term weight gain
  183. “Force-from-lipids” gating of mechanosensitive channels modulated by PUFAs
  184. Reduced protein oxidation in Wistar rats supplemented with marine ω3 PUFAs
  185. Does diet matter? The use of polyunsaturated fatty acids (PUFAs) and other dietary supplements in inflammation-associated depression
  186. Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype
  187. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement
  188. Influence of genetic variants in FADS2 and ELOVL2 genes on BMI and PUFAs homeostasis in children and adolescents with obesity
  189. Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion
  190. Dietary fish hydrolysate supplementation containing n-3 LC-PUFAs and peptides prevents short-term memory and stress response deficits in aged mice
  191. n-3 PUFAs protect against adiposity and fatty liver by promoting browning in postnatally overfed male rats: a role for NRG4
  192. Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats
  193. Agonistic effect of polyunsaturated fatty acids (PUFAs) and its metabolites on brain-derived neurotrophic factor (BDNF) through molecular docking simulation
  194. n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women
  195. Saturated fatty acids, MUFAs and PUFAs regulate ferroptosis
  196. The effects of vitamin E and omega-3 PUFAs on endothelial function among adolescents with metabolic syndrome
  197. Nutrient biomarkers shape individual differences in functional brain connectivity: Evidence from omega‐3 PUFAs
  198. Capsaicin analogues derived from n-3 polyunsaturated fatty acids (PUFAs) reduce inflammatory activity of macrophages and stimulate insulin secretion by β-cells in …
  199. PUFAs acutely affect triacylglycerol-derived skeletal muscle fatty acid uptake and increase postprandial insulin sensitivity
  200. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial
  201. PPARα-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasis
  202. Motivational factors for consuming omega-3 PUFAs: An exploratory study with Danish consumers
  203. Development of a food-exchange model to replace saturated fat with MUFAs and n–6 PUFAs in adults at moderate cardiovascular risk
  204. Krill oil treatment increases distinct PUFAs and oxylipins in adipose tissue and liver and attenuates obesity-associated inflammation via direct and indirect mechanisms
  205. The marine halophytes Carpobrotus edulis L. and Arthrocnemum macrostachyum L. are potential sources of nutritionally important PUFAs and metabolites with …
  206. Biosynthesis of LC-PUFAs and VLC-PUFAs in Pampus argenteus: Characterization of Elovl4 Elongases and Regulation under Acute Salinity
  207. The role of vitamin D and omega-3 PUFAs in islet transplantation
  208. Effects of combined d-fagomine and omega-3 PUFAs on gut microbiota subpopulations and diabetes risk factors in rats fed a high-fat diet
  209. Protective effect of ω-3 polyunsaturated fatty acids (PUFAs) on sodium nitroprusside–induced nephrotoxicity and oxidative damage in rat kidney
  210. Dietary LA and sex effects on oxylipin profiles in rat kidney, liver, and serum differ from their effects on PUFAs
  211. Association between fish and shellfish, and omega-3 PUFAs intake and CVD risk factors in middle-aged female patients with type 2 diabetes
  212. Polyunsaturated Fatty Acids (PUFAs) Content of the Fungus Mortierella alpina Isolated from Soil
  213. Hepatoprotective effect of Omega-3 PUFAs against acute paracetamol-induced hepatic injury confirmed by FTIR
  214. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier
  215. … acid composition on growth, fatty acids composition and hepatic lipid metabolism in juvenile turbot (Scophthalmus maximus L.) fed diets with required n3 LC-PUFAs
  216. Dietary Echium Oil Increases Long-Chain n–3 PUFAs, Including Docosapentaenoic Acid, in Blood Fractions and Alters Biochemical Markers for Cardiovascular …
  217. Role of PUFAs, the precursors of endocannabinoids, in human obesity and type 2 diabetes
  218. All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts
  219. The effects of plant growth regulators on cell growth, protein, carotenoid, PUFAs and lipid production of Chlorella pyrenoidosa ZF strain
  220. Lipase-catalyzed methanolysis of microalgae oil for biodiesel production and PUFAs concentration
  221. Dietary cholesterol increases the risk whereas PUFAs reduce the risk of active tuberculosis in Singapore Chinese
  222. PUFAs supplementation affects the renal expression of pannexin 1 and connexins in diabetic kidney of rats
  223. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression
  224. In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice
  225. Detection of conjugated C16 PUFAs in rat tissues as possible partial beta-oxidation products of naturally occurring conjugated linoleic acid and its metabolites
  226. Enzymatic ethanolysis of fish oil for selective concentration of polyunsaturated fatty acids (PUFAs) with flexible production of corresponding glycerides and ethyl esters
  227. Comparative analysis reveals unexpected genome features of newly isolated Thraustochytrids strains: on ecological function and PUFAs biosynthesis
  228. Milk Fatty Acid Profiles in Different Animal Species: Focus on the Potential Effect of Selected PUFAs on Metabolism and Brain Functions
  229. Endogenous n-3 polyunsaturated fatty acids (PUFAs) mitigate ovariectomy-induced bone loss by attenuating bone marrow adipogenesis in FAT1 transgenic …
  230. n–3 long-chain PUFAs reduce respiratory morbidity caused by iron supplementation in iron-deficient South African schoolchildren: a randomized, double-blind …
  231. Metabolic shift induced by ω-3 PUFAs and rapamycin lead to cancer cell death
  232. ω-3 PUFAs and resveratrol differently modulate acute and chronic inflammatory processes
  233. Short-term consumption of n-3 PUFAs increases murine IL-5 levels, but IL-5 is not the mechanistic link between n-3 fatty acids and changes in B-cell populations
  234. Asymmetric binding and metabolism of polyunsaturated fatty acids (PUFAs) by CYP2J2 epoxygenase
  235. Insight into the contribution of isoprostanoids to the health effects of omega 3 PUFAs
  236. GPR120 is not required for ω‐3 PUFAs‐induced cell growth inhibition and apoptosis in breast cancer cells
  237. Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified α-linolenic acid in unanesthetized rats
  238. Functions of enyolreductase (ER) domains of PKS cluster in lipid synthesis and enhancement of PUFAs accumulation in Schizochytrium limacinum SR21 using …
  239. Modulation of the mRNA of the Nlrp3 inflammasome by Morin and PUFAs in an obesity model induced by a high-fat diet
  240. … enzymatic synthesis, characterization, in vitro antioxidant capacity and oxidative stability studies of novel phosphatidylcholines with ω-3/ω-6 PUFAs and phenolic acids
  241. Effects of nitrogen and phosphorous stress on the formation of high value LC-PUFAs in Porphyridium cruentum
  242. Aging and FADS1 polymorphisms decrease the biosynthetic capacity of long-chain PUFAs: A human trial using [U-13C] linoleic acid
  243. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs
  244. Overconsumption of Omega-6 Polyunsaturated Fatty Acids (PUFAs) versus Deficiency of Omega-3 PUFAs in Modern-Day Diets: The Disturbing Factor for …
  245. Dietary supplementation with olive oil leads to improved lipoprotein spectrum and lower n-6 PUFAs in elderly subjects
  246. Effects of the combination of ω-3 PUFAs and proanthocyanidins on the gut microbiota of healthy rats
  247. Dietary intake and sources of long-chain n-3 PUFAs in German adults
  248. Changes in liver proteins of rats fed standard and high-fat and sucrose diets induced by fish omega-3 PUFAs and their combination with grape polyphenols according …
  249. PUFAs and PUAs production in three benthic diatoms from the northern Adriatic Sea
  250. Synergistic anti-tumor effects of melatonin and PUFAs from walnuts in a murine mammary adenocarcinoma model
  251. PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo
  252. Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus
  253. Omega-3 PUFAs Suppress IL-1β-Induced Hyperactivity of Immunoproteasomes in Astrocytes
  254. Targeting neuroinflammation: The therapeutic potential of ω-3 PUFAs in substance abuse
  255. Metabolic Engineering Strategies for the Enhanced Microalgal Production of Long‐Chain Polyunsaturated Fatty Acids (LC‐PUFAs)
  256. Human milk plasmalogens are highly enriched in long-chain PUFAs
  257. Influences of polyunsaturated fatty acids (PUFAs) on growth and secondary metabolite accumulation in Panax ginseng CA Meyer adventitious roots cultured …
  258. Modulation of the liver protein carbonylome by the combined effect of marine omega-3 PUFAs and grape polyphenols supplementation in rats fed an obesogenic high …
  259. Increased FADS2-derived n-6 PUFAs and reduced n-3 PUFAs in plasma of atopic dermatitis patients
  260. Exogenous polyunsaturated fatty acids (PUFAs) alter phospholipid composition, membrane permeability, biofilm formation and motility in Acinetobacter baumannii
  261. Effect of feeding barbel larvae (Barbus barbus (L, 1758)) Artemia sp. nauplii enriched with PUFAs on their growth and survival rate, blood composition …
  262. Effects of concentrates with different contents of protected fat rich in PUFAs on the performance lactating Granadina goats: Part II. Milk production and composition
  263. Association of serum phospholipid PUFAs with cardiometabolic risk: beneficial effect of DHA on the suppression of vascular proliferation/inflammation
  264. Therapeutic management of canine atopic dermatitis by combination of pentoxifylline and PUFAs
  265. PUFAs enhance oxidative stress and apoptosis in tumour cells exposed to hypericin-mediated PDT
  266. Regulation mechanism of silkworm pupa oil PUFAs on cholesterol metabolism in hepatic cell L‐02
  267. Quality evaluation of Oviductus Ranae based on PUFAs using HPLC fingerprint techniques combined with chemometric methods
  268. Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute …
  269. Effect of dietary n− 3 LC-PUFAs on plasma vitellogenin, sex steroids, and ovarian steroidogenesis during vitellogenesis in female silver pomfret (Pampus argenteus) …
  270. Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
  271. Transcriptomic Profiling and Gene Disruption Revealed that Two Genes Related to PUFAs/DHA Biosynthesis May be Essential for Cell Growth of Aurantiochytrium sp.
  272. ω3-PUFAs exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients
  273. Significant enrichment of polyunsaturated fatty acids (PUFAs) in the lipids extracted by supercritical CO2 from the livers of Australian rock lobsters (Jasus edwardsii)
  274. Use of n-3 PUFAs can decrease the mortality in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis
  275. Association of n-6 PUFAs with the risk of diabetic retinopathy in diabetic patients
  276. PUFAs in serum cholesterol ester and oxidative DNA damage in Japanese men and women
  277. Elovl4 and Fa2h expression during rat spermatogenesis: a link to the very-long-chain PUFAs typical of germ cell sphingolipids [S]
  278. A combination of Omega-3 PUFAs and COX inhibitors: a novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation
  279. Induction of apoptosis and lipogenesis in human preadipocyte cell line by n −3 PUFAs
  280. Metabolomic approach to the nutraceutical effect of rosemary extract plus Ω-3 PUFAs in diabetic children with capillary electrophoresis
  281. UV effects on stoichiometry and PUFAs of Selenastrum capricornutum and their consequences for the grazer Daphnia magna
  282. Erythrocyte PUFAs, circulating acylcarnitines, and metabolic syndrome risk: a prospective study in Chinese [S]
  283. Maternal pre-pregnancy weight status modifies the influence of PUFAs and inflammatory biomarkers in breastmilk on infant growth
  284. Atypical surface behavior of ceramides with nonhydroxy and 2-hydroxy very long-chain (C28–C32) PUFAs
  285. Effect of polyunsaturated fatty acids (PUFAs) on airway epithelial cells’ tight junction
  286. The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients
  287. Correction: N-3 Polyunsaturated Fatty Acids (PUFAs) reverse the impact of early-life stress on the gut microbiota
  288. n− 3 PUFAs—From dietary supplements to medicines
  289. Beneficial effects of an endogenous enrichment in n3‐PUFAs on Wnt signaling are associated with attenuation of alcohol‐mediated liver disease in mice
  290. Production of C20 polyunsaturated fatty acids (PUFAs) by pathway engineering: identification of a PUFA elongase component from Caenorhabditis elegans
  291. Production of gymnemic acid from hairy root cultures of Gymnema sylvestre R. Br. as influenced by polyunsaturated fatty acids (PUFAs) and their antioxidant activity
  292. n-3 PUFAs improve erythrocyte fatty acid profile in patients with small AAA: a randomized controlled trial
  293. A novel clean process for the combined production of fatty acid ethyl esters (FAEEs) and the ethyl ester of polyunsaturated fatty acids (PUFAs) from microalgae oils
  294. Linoleic acid intake and reduction in mortality: the icing on the cake of health benefits from n–6 PUFAs?
  295. Higher erythrocyte n–3 PUFAs are associated with decreased blood pressure in middle-aged and elderly chinese adults
  296. Regulatory Effects of N-3 PUFAs on Pancreatic β-cells and Insulin-sensitive Tissues
  297. Supplementation of polyunsaturated fatty acids (PUFAs) and aerobic exercise improve functioning, morphology, and redox balance in prostate obese rats
  298. The status of ω-3 PUFAs influence chronic unpredicted mild stress-induced metabolic side effects in rats through INSIG/SREBP pathway
  299. Plasma glycerophospholipid profile, erythrocyte n–3 PUFAs, and metabolic syndrome incidence: a prospective study in Chinese men and women
  300. Long-chain n-3 PUFAs from fish oil enhance resting state brain glucose utilization and reduce anxiety in an adult nonhuman primate, the grey mouse lemur
  301. Effects of concentrates with different contents of protected fat rich in PUFAs on the performance of lactating Granadina goats: 1. Feed intake, nutrient digestibility, N …
  302. The effect of oral administration of PUFAs on the matrix metalloproteinase expression in gastric adenocarcinoma patients undergoing chemotherapy
  303. Effects of dietary n‐3 long‐chain polyunsaturated fatty acids (n‐3 LC‐PUFAs) on growth performance, body composition and subcutaneous adipose tissue …
  304. Effects of PUFAs on animal reproduction: male and female performances and endocrine mechanisms
  305. Diets enriched in PUFAs at an early postimplantation stage prevent embryo resorptions and impaired mTOR signaling in the decidua from diabetic rats
  306. Association of PLA2G4A with myocardial infarction is modulated by dietary PUFAs
  307. Combined urea complexation and argentated silica gel column chromatography for concentration and separation of PUFAs from tuna oil: based on improved DPA …
  308. Production of transgenic beef cattle rich in n-3 PUFAs by somatic cell nuclear transfer
  309. Quality changes of N-3 PUFAs enriched and conventional eggs under different home storage conditions with wireless sensor network
  310. ω-3 PUFAs, breast and prostate cancer: experimental studies
  311. Iodine, PUFAs and Iodolipids in Health and Diseases: An Evolutionary Perspective.
  312. n-3 PUFAs and heart failure
  313. Formation of conjugated diene and triene products in lipoxygenase oxidation of C18, C20, C22 PUFAs
  314. DHA-rich n-3 PUFAs intake from the early-and mid-pregnancy decreases the weight gain by affecting the DNA methylation status among Chinese Han infants
  315. Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure
  316. Poor infant inhibitory control predicts food fussiness in childhood–a possible protective role of n-3 PUFAs for vulnerable children
  317. Effect of Milk-Based Infant Formula Fortified with PUFAs on Lipid Profile, Growth and Micronutrient Status of Young Children: A Randomized Double-Blind Clinical …
  318. Plastidic Δ6 Fatty-Acid Desaturases with Distinctive Substrate Specificity Regulate the Pool of C18-PUFAs in the Ancestral Picoalga Ostreococcus tauri
  319. Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy
  320. n-6 PUFAs downregulate expression of the tricarboxylate carrier in rat liver by transcriptional and posttranscriptional mechanisms
  321. … fatty acids (PUFAs) between animal studies and clinical meta-analyses: a review with several strategies to enhance the beneficial effects of n-3 PUFAs
  322. Investigation of the physiological properties and synthesis of PUFAs from thraustochytrids and its electrophoretic karyotypes
  323. n-3 PUFAs: an elixir in prevention of colorectal cancer
  324. Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU
  325. Ileum Gene Expression in Response to Acute Systemic Inflammation in Mice Chronically Fed Ethanol: Beneficial Effects of Elevated Tissue n-3 PUFAs
  326. Effects of polyunsaturated fatty acids (PUFAs) on gonadal maturation and spawning of striped gourami, Colisa fasciatus
  327. Unique thermal behavior of sphingomyelin species with nonhydroxy and 2-hydroxy very-long-chain (C28-C32) PUFAs
  328. … factors for two-stage cultivation of newly isolated oleaginous microalgae from local lake as promising sources of pigments, PUFAs and biodiesel feedstocks
  329. … (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of …
  330. Associations between long-chain PUFAs in maternal blood, cord blood, and breast milk and offspring body composition up to 5 years: follow-up from the INFAT study
  331. PCSK9 variant, long-chain n–3 PUFAs, and risk of nonfatal myocardial infarction in Costa Rican Hispanics
  332. Composition of long chain polyunsaturated fatty acids (LC-PUFAs) in different encephalic regions and its association with behavior in spontaneous hypertensive rat …
  333. Assessment of Arabian Gulf Seaweeds from Kuwait as Sources of Nutritionally Important Polyunsaturated Fatty Acids (PUFAs)
  334. Plasma and Red Blood Cell PUFAs in Home Parenteral Nutrition Paediatric Patients—Effects of Lipid Emulsions
  335. Omega‐3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet?
  336. Quantification of the major ω-3, ω-6 PUFAs using the Purdie assay and their ratios in different cholesterol types and the effects of gender and cholesterol on PUFA …
  337. Health benefits of polyunsaturated fatty acids (PUFAs)
  338. trans Isomeric fatty acids are inversely related to the availability of long-chain PUFAs in the perinatal period
  339. Allylic hydrogen abstraction II. H-abstraction from 1, 4 type polyalkenes as a model for free radical trapping by polyunsaturated fatty acids (PUFAs)
  340. Dietary intake and adipose tissue content of long-chain n–3 PUFAs and subsequent 5-y change in body weight and waist circumference
  341. Elaidic, vaccenic, and rumenic acid status during pregnancy: association with maternal plasmatic LC-PUFAs and atopic manifestations in infants
  342. Regulation of cholesterol metabolism in liver: link to NAFLD and impact of n-3 PUFAs
  343. Granulation Tissue Enhanced with Aspirin and Omega‐3 PUFAs as a Local Adjunct to the Surgical Treatment of Periodontitis
  344. Luminal Bioavailability of Orally Administered ω-3 PUFAs in the Distal Small Intestine, and Associated Changes to the Ileal Microbiome, in Humans with a Temporary …
  345. Effect of PUFAs oral administration on the amount of apoptotic caspases enzymes in gastric cancer patients undergoing chemotherapy
  346. Enrichment of omega‐3 PUFAs from fur seal oil
  347. C19 odd-chain polyunsaturated fatty acids (PUFAs) are metabolized to C21-PUFAs in a rat liver cell line, and curcumin, gallic acid, and their related compounds inhibit …
  348. Identification and characterization of a novel enzyme related to the synthesis of PUFAs derived from Thraustochytrium aureum ATCC 34304
  349. P4: PEMT, PCs, PUFAs, and prematurity
  350. Effect of pretreatment with omega-3 polyunsaturated fatty acids (PUFAs) on hematological parameters and platelets aggregation in patients during elective coronary …
  351. A third-generation lipid emulsion that contains n–3 long-chain PUFAs preserves retinal function in parenterally fed neonatal piglets
  352. Efficiency of PUFAs incorporation from marine sources in yolk egg’s laying hens
  353. Maternal n-3 PUFAs deficiency during pregnancy inhibits neural progenitor cell proliferation in fetal rat cerebral cortex
  354. Potential toxicity of microalgal polyunsaturated fatty acids (PUFAs).
  355. PC60 SPANISH PREGNANT WOMEN’S PLASMA PHOSPHOLIPIDS LC-PUFAs CONCENTRATIONS & ITS INFLUENCE ON THEIR NEWBORNS
  356. Transgenic pigs carrying a synthesized fatty acid desaturase gene yield high level of co-3 PUFAs
  357. Amyotrophic Lateral Sclerosis Risk, Family Income, and Fish Consumption Estimates of Mercury and Omega-3 PUFAs in the United States
  358. Plant n-3 PUFA intake may lower the risk of atherosclerotic cardiovascular disease only among subjects with a low intake of marine n-3 PUFAs
  359. Are There Benefits to Growth with Supplementing Long-Chain PUFAs to Toddlers Born Prematurely?
  360. ω-3 PUFAs and prostate cancer: epidemiological studies
  361. Dietary marine n–3 PUFAs do not affect stress-induced visceral hypersensitivity in a rat maternal separation model
  362. Effect of parenteral lipid emulsion on preterm infant PUFAs and their downstream metabolites
  363. Influence of omega-3 PUFAs on the metabolism of proanthocyanidins in rats
  364. Lipoic Acid Prevents Suppression of Connective Tissue Proliferation in the Rat Liver Induced by n–3 PUFAs
  365. Using polyunsaturated fatty acids (PUFAs) as functional ingredients
  366. Thermal behavior of liposomes containing PCs with long and very long chain PUFAs isolated from retinal rod outer segment membranes
  367. Preparation of n-3 PUFAs ethyl esters by an efficient biocatalyzed solvent-free process
  368. Effect of marine vegetal sources on the hen diets on the PUFAs and PUFAs n-3 in laying hens egg yolk and plasm
  369. Favorable effects of omega-3 PUFAs on glucose control in an adolescent with type 1 diabetes using continuous glucose monitoring: a case report
  370. Content of polyunsaturated fatty acids (PUFAs) in serum and liver of rats fed restricted diets supplemented with vitamins B2, B6 and folic acid
  371. Identification of genes selectively regulated in human hepatoma cells by treatment with dyslipidemic sera and PUFAs
  372. Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for …
  373. Development of meat and poultry products enriched with n-3 PUFAs and their functional role
  374. Novel “Matrix-Corrected Calibration” study for the detection of polyunsaturated fatty acids (PUFAs) in plasma and erythrocytes by means of a gas chromatography …
  375. Effects of supplementation of the Tris-egg yolk extender with n-3 polyunsaturated fatty acids (PUFAs) on frozen-thawed ram semen characteristics
  376. Effects of dietary long chain PUFAs on hippocampal lipid peroxidation and NMDA receptor subunits A and B concentration in streptozotocin-diabetic rats
  377. The role of serum monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) in cardiovascular disease risk
  378. Effects of dietary omega-3 PUFAs on growth and development: Somatic, neurobiological and reproductive functions in a murine model
  379. Direct esterification method for analysis of long-chain polyunsaturated fatty acids (LC-PUFAs) in infant formulae
  380. Egg yolk enriched with polyunsaturated fatty acids (PUFAs) improves the shelf life of ram semen in liquid storage
  381. Variability in the cardiometabolic effects of ω-3 long-chain PUFAs: background diet, timing, and genetics
  382. Effects of PUFAs in a mouse model of HSV-1 chorioretinitis
  383. Insights into the function of n-3 PUFAs in fat-1 transgenic cattle
  384. ω-3 PUFAs: Interventional Trials for the Prevention and Treatment of Breast and Prostate Cancer
  385. Effect of fodder enrichment with PUFAs on quail eggs
  386. Effects of baked and raw salmon fillet on lipids and n-3 PUFAs in serum and tissues in Zucker fa/fa rats​​​​​​​​​​​​​​​​​​​​
  387. Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter
  388. Two sides of the same coin: NEO‐PUFAs in Rett syndrome and post‐infarction cardiac arrhythmias
  389. Effects of n-3 PUFAs on intestinal mucosa innate immunity and intestinal microbiota in mice after hemorrhagic shock resuscitation
  390. Functional LC ω‐3 PUFAs in pregnancy: a short review of the literature
  391. Influence of dietary n‐3 polyunsaturated fatty acids (PUFAs) on growth, PUFA composition and the expression of FAD6 and ELOV5 in pacific white shrimp …
  392. ω-3 PUFAs and colon cancer: experimental studies and human interventional trials
  393. Combination of low dose major n3 PUFAs in fresh water mussel lipid is an alternative of EPA–DHA supplementation in inflammatory conditions of arthritis and LPS …
  394. Microalgae as a Source of Functional PUFAs: A Green Low-cost Pathway via Enzymatic Hydrolysis
  395. A weighty matter: can PUFAs in pregnancy prevent obesity?
  396. Modulation of plasma levels and percentages of incorporation of ω-3 PUFAs in egg yolk under the influence of supplementation sources rich in omega 3 to diet of …
  397. Abstract P1-03-12: The ratio of omega-3 to omega-6 PUFAs impact cancer cell phenotype in the tumor microenvironment
  398. Polyunsaturated fatty acids (PUFAs) OF MUCOR sp. with special reference to gamma linolenic acid (GLA)
  399. Effects of polyunsaturated fatty acids (PUFAs) in the treatment of experimental chronic renal failure
  400. Effect of PUFAs from Pteleopsis suberosa stem bark on androgenic enzymes, cellular ATP and prostatic acid phosphatase in mercury chloride–exposed rat
  401. Losses in n-3 PUFAs during oxidation of fish lipids
  402. Exogenous polyunsaturated fatty acids (PUFAs) promote changes in growth, phospholipid composition, membrane permeability and virulence phenotypes in …
  403. Rice bran in the diet as an enriching source of long chain Omega (n-3) poly unsaturated fatty acids (LC n-3 PUFAs) in fillets of genetically improved farmed …
  404. Oxidative stress and cancer: Role of n-3 PUFAs
  405. Effects of supplementation with fish oil and n-3 PUFAs enriched egg yolk phospholipids on anhedonic-like response and body weight in the rat chronic mild stress …
  406. Selective concentration of PUFAs in glyceride from fish oil with immobilized lipase
  407. The effect of PUFAs in silkworm pupa oil on serum lipids, EPA and DHA levels in rats
  408. The apoptosis-inducing effects of polyunsaturated fatty acids (PUFAs) on benign and malignant breast cells in vitro
  409. Effect of n-3 PUFAs on markers of inflammation in arthritic horses
  410. An Approach for Examining the Impact of Food Group-Based Sources of Nutrients on Outcomes with Application to PUFAs and LDL in Youth with Type 1 Diabetes
  411. The anxiolytic activity of n-3 PUFAs enriched egg yolk phospholipids in rat behavioral studies
  412. Progress in the role of ω-3 PUFAs in regulating the genesis and development of colorectal cancer
  413. Advances in the Production of PUFAs by the Culture of Mocroalgae [J]
  414. Simultaneous Enrichment of Eggs With PUFAs and Antioxidants
  415. ω-3 PUFAs and colon cancer: epidemiological studies
  416. ω-3 PUFAs in the prevention and cure of inflammatory, degenerative, and neoplastic diseases 2014
  417. Trophic Transfer of PUFAs—’Vital Ones Reach Top Predators’
  418. Anthracyclins increase free PUFAs and etherPEs with PUFAs as potential hallmarks of lipid peroxidation and ferroptosis
  419. Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study
  420. Are PUFAs n-3 really important in diet?
  421. New marine sources of polyunsaturated fatty acids (PUFAs)
  422. Alternative n-3 PUFAs Sources in Central European Diet before Westernization-Case Report from Poland
  423. LC-PUFAs in Reproduction and Behavior—’Good Cop–Bad Cop?’
  424. Influence of long-chain polyunsaturated fatty acids (LC-PUFAs) on cognitive and visual development
  425. Triacylglycerols Participate in the Eukaryotic Pathway of PUFAs Biosynthesis in the Red Microalga Porphyridium Cruentum
  426. ω-3 Polyunsaturated fatty acids (PUFAs or fish oils) and atrial fibrillation
  427. Digestive utilization of the fat and individual fatty acids of a protected fat rich in PUFAs in goats
  428. PUFAs and risk of cognitive decline or dementia: epidemiological data
  429. Omega-3 PUFAs and gut microbiota: A preventive approach for colorectal cancer
  430. Commentary to:“The use of high-dose omega-3 PUFAs and vitamin-d co-supplementation as a therapeutic approach for ibd-related symptoms: Case report and …
  431. PUFAs and IBD: is there a relationship?
  432. Dietary profile of n‐3 series LC‐PUFAs in rainbow trout under regular stripping condition: Semen production and quality, hepato‐somatic index, haemato …
  433. PUFAs in sickle cell disease
  434. GLA PURIFICATION FROM ECHIUM FASTUOSUM SEED OIL IN A TWO‐STEP PROCESS: SIMULTANEOUS PUFAs EXTRACTION/CONCENTRATION AND …
  435. ω-3 PUFAs, why are we speaking of them?
  436. The use of high-dose omega-3 PUFAs and vitamin-d co-supplementation as a therapeutic approach for ibd-related symptoms: Case report and literature review
  437. Correction: Efficacy of omega-3 PUFAs in depression: A meta-analysis
  438. Combating atherosclerosis with heavy PUFAs: Deuteron not proton is the first
  439. A Survey on the possibility of concurrent enrichment of broiler chicken meat with CLA and n-3 type PUFAs
  440. Investigation of the mechanisms underlying the vascular relaxation mediated by n-3 PUFAs (fish oils), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) …
  441. P2253 Intake of the omega 3 PUFAs formulation EPA: DHA 6: 1 by aged rats reduced shedding of microvesicles from spleen-derived cultured leukocytes and their …
  442. Producing polyunsaturated fatty acids (PUFAs) from plant sources
  443. N-3 PUFAs and neuroinflammatory processes in cognitive disorders
  444. Corrigendum to “A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of …
  445. Effect of PUFA-rich supplements from marine sources in the feed of laying hens on lipid composition and the percentage of incorporation of n-6 PUFAs in egg yolk.
  446. Omega-3 polyunsaturated fatty acids (PUFAs) as food ingredients
  447. MP63-01 PREVENTATIVE EFFECT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS (N-3 PUFAs) AGAINST INDUCTION OF BLADDER CANCER (BC) IN A RAT …
  448. Omega-6 PUFAs and T2DM
  449. -3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases
  450. Inflammation, C-reactive protein and cardiometabolic risk: how compelling is the potential therapeutic role of n. 3 PUFAs in cardiovascular disease?
  451. n-3 polyunsaturated fatty acids (PUFAs) inhibit mast cell activation by disrupting FcϵRI association with lipid rafts (HYP3P. 401)
  452. Effect of growth media modifications on cell biomass and polyunsaturated fatty acids (PUFAs) production from Shewanella frigidimarina
  453. Caracterización de diversas especies de peces como fuente de PUFAs y omega 3 según su perfil de ácidos grasos
  454. … OF PRETERM FORMULAS (PTF) WITH A LOW-EPA FISH OIL: EFFECT ON POLYUNSATURATED FATTY ACIDS (PUFAs) STATUS AND GROWTH.
  455. Supplementing Mothers and their Offspring with Long-Chain ω–3 PUFAs Offers no Benefit Compared with Placebo in Infant Development
  456. NIR Spectroscopy: A Non-destructive method for PUFAs determination of forage from permanent grassland
  457. MON-129 Analysis of Omega3 PUFAs Status Among the Female and Male Population of the Moscow Region
  458. Research on Synthesis Technology of PUFAs Glyceride [J]
  459. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in [greater than or equal to] 75 years old patients: A randomized …
  460. Omega‐3 polyunsaturated fatty acids (n‐3 PUFAs) induce apoptosis in breast cancer cells through activation and translocation of neutral sphingomyelinase‐2 (N …
  461. Eect of 3 months dietary supplementation with omega-3 α-linolenic acid (ala) and polyunsaturated fatty acids (PUFAs)(Alphalife Freia Framaceutici Srl) …
  462. Dietary n-3 PUFAs augment caspase 8 activation in Staphylococcal aureus enterotoxin B stimulated T-cells
  463. STUDIES ON THE IN VITRO ANTITUMOR ACTIVITY OF PUFAs AND CORRESPONDING Se-PUFAs
  464. Transgenic n-3 PUFAs Enrichment Regulates Related Physiological Activities by Affecting Nerves
  465. A primary study on the extraction and enrichment of the PUFAs from algae
  466. Almonds and walnuts consumption modifies PUFAs profiles and improves metabolic inflammation beyond the impact on anthropometric measure
  467. Endogenous production of n-3 PUFAs protects mice from CCl4 -induced liver fibrosis by regulating mTOR and Bcl-2/Bax signaling pathways.
  468. Influence of Microalgae Dietary Administration on ω3 LC-PUFAs Meat Content of Muscovy Duck
  469. Influence of canola oil in broiler diets and its effects of MUFAs and PUFAs contents in selected tissues.
  470. Assessment of the effect of the increased content of vegetable oils rich in PUFAs on the fatty acid composition and quality of beef
  471. Beneficial potency of algae-based polyunsaturated fatty acids (PUFAs) for cancer therapy
  472. … Role in Extending Lifespan and Reproductive Capacity in White Leghorn Laying Hens; and the Effect of Polyunsaturated Fatty Acids (PUFAs) on Lipid Metabolism …
  473. Effect of n-3 polyunsaturated fatty acids (PUFAs) on lipid peroxidation, plasma homocysteine levels and antioxidant status in normolipidemic subjects
  474. Dietary supplementation with PUFAs rescues the eggshell defects caused by seipin mutations in C. elegans
  475. Therapeutic efficacy of a nutritional combination of n-3 PUFAs and Arctium Llappa extract on canine atopic dermatitis
  476. Farm-made feed for polyunsaturated fatty acids (PUFAs) rich carp production in India: a case study
  477. Effect of PUFAs on extracellular matrix production and remodeling in vascular smooth muscle cell cultures in an atherosclerotic model
  478. Using antioxidant to enhance liver cancer preventive effect of n-3 PUFAs
  479. Front Cover: ω‐3 PUFAs Alleviate High‐Fat Diet–Induced Circadian Intestinal Microbes Dysbiosis
  480. Determination of LC-PUFAs and Protein Content in Premature infant formula powders by ATR-FTIR Spectroscopy and Chemometrics
  481. Production of PUFAs as Dietary and Health Supplements from Oleaginous Microalgae Utilizing Inexpensive Renewable Substrates
  482. Serum Urate, PUFAs and Abdominal Obesity in Hispanic Children: The Viva La Familia Study
  483. Isolation and Evaluation of Anti-inflammatory activity of Epigallocatechin from Senegalia rugata along with PUFAs
  484. Plastidic Δ6 fatty-acid desaturases with distinctive substrate specificity regulate the pool of c18-PUFAs in the ancestral picoalga ostreococcus tauri
  485. Effects of Culture Medium on PUFAs Production by Mortierella isabellinas
  486. PUFAs and Their Metabolites in Carcinogenesis
  487. Kid goat deposits composition in response to maternal intake of a protected fat rich in PUFAs
  488. Additional data from our study on fatty acids variations during lactation: Correlations between n-3 and n-6 PUFAs in human colostrum, transitional, and mature milk
  489. Serum polyunsaturated fatty acid (PUFAs) levels as a risk factor for the post-operative development of venous thromboembolism (VTE) in patients with end-stage knee …
  490. The Use of Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Atrial Fibrillation
  491. Molecular Mechanism of Anti-cancer Action of PUFAs with Particular Reference to GLA in Glioma
  492. The effects of polyunsaturated fatty acids (PUFAs) on the sleep parameters of the rat pups.
  493. Conditional ablation of retinal ELOVL4 reveals a key role in synthesis of VLC-PUFAs and photoreceptor light responses
  494. Long-chain omega-3 PUFAs and their role in healthy ageing
  495. PC59 DIETARY INTAKE IN PREGNANT WOMEN INFLUENCES PLASMA PHOSPHOLIPIDS LC-PUFAs IN THEIR NEONATES
  496. 310 Relationship between concentrations of omega-3 PUFAs with apolipoproteins in the Cree population from the James bay territories, Québec, Canada
  497. Lipid profile of the yolk under the influence of supplementaries sources rich in Ω-3 PUFAs in the diet of laying hens in the time.
  498. Review on the Regulatory Mechanisms of n-3 PUFAs on Lipid Metabolism and Inflammation-immunity
  499. Study on the extraction of PUFAs from Laminaria japonica with supercritical CO_2
  500. Metabolic and Metabolomic Insights Regarding the Omega-3 PUFAs Intake in Type 1 Diabetes Mellitus
  501. Optimization of Polyunsaturated Fatty Acids (PUFAs) Production from Olive Cake by Pseudomonas fluorescens NBRC14160 using Response Surface Methodology …
  502. NAT–2. Report# 1: High HDL and Low PUFAs Levels in Exudative AMD Patients
  503. P5379 Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular-and all-cause mortality in chronic haemodialysis patients
  504. Role of n-3 PUFAs in inflammation via resolvin biosynthesis
  505. Research Progress on Fungi Mutation Breeding for Producing PUFAs
  506. The Balance of n6/n3 Polyunsaturated Fatty Acid (PUFAs) is an Important Determinant Factor of Prognosis after Acute Myocardial Infarction
  507. Oxidative Stress and Inflammatory Factors in Lung Cancer: Role of n-3 PUFAs
  508. ω-3 PUFAs and Other Cancers
  509. Despite higher n‐6 PUFAs, butter remains a reliable source of saturated fats across the world
  510. Efficacy of omega-3 PUFAs in depression: A meta-analysis
  511. The Determination of ω-Fatty Acids (PUFAs) Effect on caspase-8 gene expression of stomach in patients infected with H. pylori
  512. … of PUFA-rich dietary supplements from marine sources in the feed of laying hens on lipid composition and the percentage of incorporation of n-3 PUFAs in egg yolk.
  513. The construction of pichia pastoris to produce polyunsa turated fatty acids (PUFAs)
  514. The Urgent Need to Re-Think Outside the” Omega-3 PUFAs” Box
  515. … (3-Hydroxy, 3-Methylglutaryl-CoA Reductase) Activity of Cultured Rat Brain Cells: Sensitivity to n-3 and n-6 Polyunsaturated Fatty Acids (PUFAs) from Cod-Liver and …
  516. A study on correlation coefficients between fatty acids in the meat of chickens fed fatty acids (PUFAs) rich diets
  517. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids (PUFAs) in the secondary prevention after myocardial infarction (MI).
  518. Does the intake of LC-PUFAs during pregnancy affect the body composition of term neonates? Preliminary results
  519. 1742-P: Blockade and Reversal of Autoimmunity and Type 1 Diabetes through Gene-Therapeutic and Nutritional Intervention of Elevating ω-3 PUFAs
  520. Healthy polyunsaturated fatty acids (PUFAs) for food enrichment.
  521. 5-Lipoxygenase Mediates The Anti-angiogenic Effects Of-3 PUFAs In Proliferative Retinopathy
  522. The influence of ω-3 PUFAs on chemo-or radiation therapy for cancer
  523. Effect of Omega 3 Polyunsaturated Fatty Acids (PUFAs) on Markers of Inflammation in Young Horses in Training
  524. Conversion of n-3 polyunsaturated fatty acids (PUFAs) and incorporation of docosahexaenoic acid (DHA) in cultured neural cells
  525. Contribution of Dietary PUFAs and Micronutrients in the Protection against Food Allergy Development
  526. Gene Expression Analysis Of Retinas From-3-PUFAs And-6-PUFAs Fed Mice In Oxygen-induced Retinopathy (OIR) Model
  527. Plasma n-3 PUFAs, Cognitive Decline, and White Matter Mediation (P02. 058)
  528. A study on the accumulation of omega-3 PUFAs in egg yolk
  529. Cytochrome P450‐Derived Epoxy Lipids of N‐3 PUFAs Protect the Heart From Ischemia‐Reperfusion Injury by Regulating Mitochondrial Sirtuin 3
  530. Biotechnology for a Sustainable Aquaculture: Selection of Safe Marine Bacteria Producers of LC-PUFAs and Antimicrobials
  531. … role in extending lifespan and reproductive capacity in White Leghorn laying hens; and the effect of polyunsaturated fatty acids (PUFAs) on lipid metabolism …
  532. Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Early-Screening Platform of Anti-Arrhythmic Effects by PUFAs
  533. Polyunsaturated fatty acids (PUFAs) differentially affected abca1-mediated cholesterol efflux from cholesterol-loaded mouse or human macrophages
  534. Omega-3 PUFAs in children with ADHD
  535. … AND N-3/N-6 PUFAs MEMBRANE ABNORMALITIES IN PATIENTS WITH SCHIZOPHRENIA ARE NOT ASSOCIATED WITH SERUM N-3/N-6 PUFAs
  536. Potential and Enzymatic Characterizations of Marine Yeast for PUFAs from Balai Taman Nasional Karimunjawa
  537. The effects of Omega-3, Omega-6 Polyunsaturated Fatty Acids (PUFAs) and Vitamin E on patients with the remitting-relapsing (RR) form of Multiple Sclerosis (MS) in …
  538. New pharmaceutical insights related to the pathways of PUFAs.
  539. Endocannabinoids derived from n-3 PUFAs-Formation, release and possible roles in inflammation and obesity
  540. Comparison Study on the Relative Rates in Heat-Driven Oxidation of PUFAs
  541. Alpha-lipoic acid prevents n-3 PUFAs induced suppression of wound healing
  542. n-3 PUFAs as Modulators of Stem Cells in Prevention of Colorectal Cancer
  543. Biomass production and fatty acids long chain polyunsaturated omega 3 (LC-PUFAs) Chilean strain using thraustochytrids
  544. From arthritis to omega—PUFAs regulate OA in obesity
  545. THU0279 POLYUNSATURATED FATTY ACIDS (PUFAs) AND SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS) ARE DECREASED IN PLASMA AND SERUM …
  546. Supplementation of Omega-3 PUFAs could improve long term prognosis after pci in patients without hyperlipidemia and diabetes
  547. Reactive aldehydes formed from peroxidation of n‐6 and n‐3 PUFAs have differential effects on mitochondrial function in heart
  548. Effects of n-3 PUFAs on depression induced by chronic mild stress in adult male pups experienced maternal separation at early life
  549. THE DOSE-DEPENDENT EFFECTS OF DIFFERENT PUFAs ON ADIPONECTIN AND PPAR γ EXPRESSIONS IN ADIPOCYTES
  550. Is the vascular TREK-1 potentially involved in PUFAs-induced neuronal activation
  551. Abstract A111: Endogenous conversion of n-6 PUFAs to n-3 PUFAs prevents progression of K-Ras activated pancreatic lesion development to pancreatic ductal …
  552. nJ3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral …
  553. Omega‐3 polyunsaturated fatty acids (n‐3 PUFAs) improve survival following myocardial infarction and inhibit phenylephrine‐induced hypertrophy by regulating …
  554. Morakot Tanticharoen Published: Fungal Genetic and Biology, Vol. 37, No. 1, October 2002, pp. 13-21 Polyunsaturated fatty acids (PUFAs), namely, oleic (C18: l) …
  555. Dietary n-3 PUFAs affect the mRNA expression of satiety regulators in diet-induced obese mice
  556. The influence of combined buckwheat D-fagomine and fish omega-3 PUFAs on beneficial gut bacteria in rats
  557. Determination of expression of regulatory cells of cell cycle S phase in patients with gastric adenocarcinoma with oral administration of PUFAs before and after …
  558. PUFAs Attenuate Blood Lipids and LPS-Inducible Inflammation and ER stress in Adipocyte Tissue in ob/ob Mice
  559. Absorption and Delivery of Synthetic VLC-PUFAs to Mouse Retina
  560. … of Long-chain Polyunsaturated Fatty Acids (LC-PUFAs) in Serum, RBC and Fat with Very-long-chain Polyunsaturated Fatty Acids (VLC-PUFAs) in Human Retina
  561. P2-250 Omega 3 polyunsaturated fatty acids (PUFAs) and risk of early onset prostate cancer
  562. Dietary n-3 PUFAs affect the blood pressure rise and the cardiac function modulation in a hyperinsulinemia rat model in vivo
  563. The Effect of Omega-3 PUFAs on Enterobacter aerogenes
  564. Differences in the Biosynthesis of Long Chain Omega‐3 and Omega‐6 Polyunsaturated fatty acids (PUFAs) between African and European American patients with …
  565. Effects of n-3, n-6 PUFAs and their derivatives on KV7. 1/KCNE1 channels
  566. OMEGA-3 PUFAs IMPROVED ENDOTHELIAL FUNCTION AND LEFT VENTRICLE GLOBAL LONGITUDINAL STRAIN IN PATIENTS WITH SYSTOLIC HEART …
  567. 3 Polyunsaturated fatty acids (PUFAs) and specialized pro-resolving mediators (SPMs) are decreased in plasma and serum from SLE patients compared to healthy …
  568. Screening of high-yield PUFAs Mortierella isabellina strain
  569. STUDY ON THE FERMENTAION FACTORS ON PRODUCTION OF PUFAs BY FERMENTATION USING MONOBLEPHARIS POLYMORPHA CORNU AG
  570. Lack of n3 VLC-PUFAs and Elovanoids correlates with impaired photoreceptor disk morphogenesis in AdipoR1 KO
  571. Marine microalgae PUFAs and synthetase genes application in tumor prevention and treatment
  572. An Approach for Examining the Impact of Food Group‐Based Sources of Nutrients on Outcomes with Application to PUFAs and LDL
  573. Anticancer effect of PUFAs is mediated by inhibition of polyisoprenylated methylated protein methyl esterase
  574. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in≥ 75 years old patients: A randomized multicenter study
  575. Correlation of LC-PUFAs in serum with VLC-PUFAs and n3/n6 VLC-PUFA ratios in human donor retinas
  576. Abnormal adipocyte-derived hormones in Rett syndrome mirroring chronic oxidative stress and inflammation: effects of ω-3 PUFAs
  577. Phosphatidylcholine (PC) molecular species-containing very long chain polyunsaturated fatty acids (VLC-PUFAs) are altered in AMD
  578. Targeted and untargeted lipidomics of oxygenated metabolites of PUFAs: a new frontier in health and disease
  579. Reduced Levels Of VLC-PUFAs Lead To Structural And Functional Changes In Rod But Not Cone Photoreceptors
  580. LC-PUFAs: Their roles in neuro-behavioural development and outcomes
  581. Influence of ω-3 PUFAs on predictors of sudden cardiac death in patients with Q-wave myocardial infarction
  582. Significance of VLC-PUFAs in Diabetic Retinas Shown in Mouse and Human Donor Eyes
  583. Eualuation of the efficacy of a dietary supplement containing polyunsaturated fatty acids (PUFAs) and uitamins in the management of dermatitis
  584. EVALUATION OF INHIBITORY POTENTIAL OF PUFAs FROM FISH OIL AGAINST MONOAMINE OXIDASE-B: A MOLECULAR DOCKING STUDY
  585. Omega-3 PUFAs and major depressive disorder
  586. Very long chain polyunsaturated fatty acids (VLC-PUFAs) in cone-and rod-rich regions of the human retina
  587. Effects of Polyunsaturated Fatty Acids (PUFAs) on Global DNA Methylation in Liver of Rats
  588. Effects of isomaltulose and high amounts of PUFAs together with elevated physical activity on subjects with a moderate metabolic risk profile before and after a 6 …
  589. Omega-3 PUFAs in patients with ischaemic heart failure
  590. Dietary Omega-3 PUFAs: In Behavior, Brain Development, and Gut Microbes
  591. Chicken Embryonic Retina as a Model for Studying the Influence of Diet on VLC-PUFAs During Development.
  592. ω-3 PUFAs ARE EFFECTIVE AGAINST WEIGHT LOSS IN CACHECTIC CANCER PATIENTS
  593. Mechanism Action of n-3 PUFAs
  594. Characterization of Diverse Fish Species as Sources of PUFAs and Omega-3 According to Their Fatty Acid Profile
  595. COX-2 Expression and Opposite Growth Effects of N-3 and N-6 PUFAs in Three Novel Pancreatic Adenocarcinoma Cell Lines
  596. Effects of Feeding EFFSB on the Content of PUFAs and CLA of Tissue of Milking Cows
  597. Abstract MP21: No Significant Association of n-3 polyunsaturated Fatty Acids (PUFAs) with T-helper Type 1 (Th1) Cells: Results From the Multi-Ethnic Study of …
  598. The role of Omega-3 PUFAs in treating the symptoms associated with schizophrenia
  599. Dietary Supplementation with Long Chain (LC) PUFAs (n-3, n-6) in Malnourished Children with Chronic Diarrhea
  600. Effects of FADS2 Inhibition in Combination with Increased Dietary n‐3 PUFAs on Skeletal Muscle Protein Turnover in Mice Fed a High Fat Diet.
  601. EFFECT OF VARYING RATIOS OF N3/N6 PUFAs ON THE GROWTH PERFORMANCES OF WHITE INDIAN PRAWN (PENAEUS INDICUS, MILINE, EDWARDS) IN …
  602. Interventional Treatment With 3-PUFAs in the Proliferative Stage of Retinopathy Attenuates Pathologic Neovascularization Through Activation of Ppar
  603. Association of Dietary Intake and RBC Biomarkers of Omega-3 PUFAs with Psychological Wellbeing Among Homeless Youth
  604. n‐3 PUFAs reorganize B cell membrane rafts and molecular order accompanied by differential effects on B cell function
  605. Polyunsaturated Fatty Acids (PUFAs) Inhibit Polyisoprenylated Methylated Protein Methyl Esterase (PMPMEase)
  606. Focus on omega-3 PUFAs in heart failure: your life and your heart
  607. Heterogeneous effect of n-3 polyunsaturated fatty acids (PUFAs) on LDL in vitro oxidation in healthy subjects
  608. Polyunsaturated fatty acids (PUFAs) alter the epigenetic landscape in MDA-MB-231 triple negative breast carcinoma (TNBC)
  609. PUFAs in clinical practice
  610. Dietary PUFAs Enhance Macrophage Autophagy, Attenuate NLRP3 Inflammasome Activation, and Reduce Atherosclerosis
  611. P1137 DIETARY INTAKE IN PREGNANT WOMEN INFLUENCES PLASMA PHOSPHOLIPIDS LC-PUFAs IN THEIR NEONATES
  612. LC-PUFAs: THEIR ROLE IN MATERNAL AND INFANT NUTRITION
  613. Plasma n‐3/n‐6 PUFAs interact with FADS2 genetic variations to affect blood cholesterol concentrations in type 2 diabetes
  614. No Significant Association of n-3 polyunsaturated Fatty Acids (PUFAs) with T-helper Type 1 (Th1) Cells: Results From the Multi-Ethnic Study of Atherosclerosis (MESA)
  615. Evaluation of Various Culture Conditions for the Production of Poly Unsaturated Fatty Acids (PUFAs) from selected Marine Micro-Algae.
  616. Research on extracting PUFAs out of Laminaria japonica by means of supercritical carbon dioxide extraction
  617. Retina Phosphatidyl Choline Molecular Species Containing DHA and VLC-PUFAs Display Cell-selective Decreases in AdipoR1 Conditional KOs
  618. The effects of different fatty acids on the expression of genes related to the synthesis of PUFAs.
  619. Recent Development in the microalgal production of omega-3, omega-6 acids and PUFAs
  620. Optimization of Extraction Technique of PUFAs from the Head of Oratosquilla De Haan by Response Surface Analysis
  621. Omega‐3 Polyunsaturated Fatty Acids (n‐3 PUFAs) Decrease Growth and microRNA‐21 Expression of Estrogen Receptor‐Positive (ER+) MCF‐7 Breast Cancer Cells
  622. Long chian PUFAs omega-3 incorporation in cell membrane microdomains of breast cancer cells
  623. Effect of n-3 PUFAs on arterial stiffness in patients with cardiovascular disease
  624. PUFAs, A Dietary Supplement and Seizure Threshold
  625. A comparison of the effects of free and microencapsulated omega-3 PUFAs on early colorectal cancer biomarkers in the azoxymethane animal model
  626. Dietary Supplementation With Long Chain Poliinsaturated Fatty Acids (Lc-PUFAs) and Recovery of Malnourished Children With Chronic Diarrhea
  627. Effect of dietary PUFAs and vitamin E on allergic responses to peanut in a murine food allergy model
  628. Adiponectin receptor 1 (AdipoR1) is necessary for the synthesis of very long chain polyunsaturated fatty acids (VLC-PUFAs) in Photoreceptor Cells
  629. A comparative study of PUFAs in Algae and higher plants
  630. Kid goat adipose deposits composition in response to maternal intake of a protected fat rich in PUFAs
  631. Neuro-Preventive Effect and Elevation of Cellular Adenosine Triphosphate by PUFAs from Pteleiosis suberosa Stem Bark on Mercury Sub-Acute Exposed …
  632. Administration of alpha-Lipoic Acid Overcomes Detrimental Effects of n-3 PUFAs on Wound Healing in Rat
  633. Response to the Letter of Hester Den Ruijter and Ruben Coronel Regarding the Article” The Role of n-3 PUFAs in Preventing the Arrhythmic Risk in Patients with …
  634. Nutritional modulation of cardiotoxicity and anti‐cancer efficacy related to doxorubicin chemotherapy by glutamine and n‐3 PUFAs (123.8)
  635. OMEGA-3 PUFAs improved endothelial dysfunction and arterial stiffness with a parallel antioxidant effect in patients with metabolic syndrome
  636. … sources of supplementaries PUFAs in the diet of laying hens: effect on lipid composition of the plasma and of the egg yolk and time of incorporation of omega 6 PUFAs …
  637. EFFECTS OF POLYUNSATURATED FATTY ACIDS (PUFAs) ON GLOBAL DNA METHYLATION IN LIVER OF RATS
  638. Dietary Long‐chain PUFAs Enrich Porcine Alveolar Macrophages and Alter Prostaglandin E2 Production Following LPS Challenge
  639. PUFAs emerge as potential treatments for psychiatric disorders
  640. Risk of Parkinson’s Disease (PD) Associated with the Herbicide Paraquat Is Attenuated by High Dietary Intake of Polyunsaturated Fatty Acids (PUFAs)(S42. 004)
  641. Effect of polyunsaturated fatty acids (PUFAs) on the proliferation and extracellular matrix mineralization and gene expression of gilthead seabream skeletal cell lines
  642. Hypertension, cardiac hypertrophy and heart failure: Is there a role for n-3 PUFAs?
  643. Characterization of polyunsaturated fatty acids (PUFAs) in tropical species of fish
  644. Effects of omega-3 PUFAs on activity of NO-system after myocardial ischemia/reperfusion
  645. EFFECT OF DIETARY N-6 POLYUNSATURATED FATTY ACIDS (PUFAs) ON PROSTAGLANDINS (PG) PRODUCED BY MATERNAL INTERCOTYLEDONARY …
  646. Lactobacillus Plantarum Biocenol™ LP96 and n-3 PUFAs and their Immunomodulatory Action.
  647. Novel Role of PUFAs as Essential Cofactors for TRPV4 Function
  648. Effects of fed diets with a different n-6/n-3 PUFAs ratio on oxidative stability, and physico-chemical properties of chickens meat.
  649. Effect of selenium yeast in containing PUFAs dietary on fatty acid composition and antioxidant capacity of Hu lambs.
  650. A meta-analysis is suited to nullify the effects of n–3 PUFAs on cognitive function
  651. ADDITIONAL STUDIES ON THE EFFECT OF N-3 PUFAs ON MACROPHAGE RECRUITMENT AND CHOLESTEROL ACCUMULATION
  652. Inhibitory Effects of Omega-3 PUFAs on Cardiac Fibrosis In Vivo and In Vitro
  653. Effect of n-3 PUFAs in LPS-induced substantia nigra dopaminergic neurons injury
  654. 1TA3-08 Effects of disruption of lipid rafts by PUFAs on T cell recognition (The 47th Annual Meeting of the Biophysical Society of Japan)
  655. The association of ADHD with deficits in fatty acids (FA) and the effect of dietary supplement of n-3 PUFAs on RBC membrane FA profile in children with ADHD.
  656. EFFECT OF HEAT PROCESSING TREATMENTS ON OMEGA-3 POLYUNSATURATED FATTY ACIDS (PUFAs) IN FISH
  657. Effect of ω-3 PUFAs on regulation of Toll-like receptor 4 and nuclear factor-ΚB signaling pathway in neonatal rats with brain injury induced by LPS
  658. Effects of endogenous omega-3 polyunsaturated fatty acids (PUFAs) on psoriatic lesion and Th17 cells in IMQ-induced psoriasis-like model.
  659. Evaluation the Effect of Oral Administer PUFAs on Apoptosis in Gastric Mucosa in Patients Infected with Helicobacter Pylori
  660. Western diets high in N-6 polyunsturates (PUFAs) may increase the risk of premature birth.
  661. … that certain polyunsaturated fatty acids (PUFAs) exert cytotoxic actions for cancer cells in vitro and in vivo without affecting normal cells. Administration of PUFAs …
  662. Heavy metal effects on types and levels of Omega-3 polyunsaturated fatty acids (PUFAs) in Tilapia Fish (Oreochromis niloticus) in Winam gulf of Lake Victoria
  663. Effect of ω-3 PUFAs on the retinal neovascularrization.
  664. The Association Between Erythrocyte n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Content and Inflammation in Male Patients With Peripheral Artery Disease …
  665. Conditional Depletion of Retinal VLC-PUFAs Causes Retinal Dysfunction
  666. Egg design–new formulation by enrichment of PUFAs using natural substances
  667. Cultivation of PUFAs producing Sicyoidochytrium minutum strain using by-products from agriculture
  668. Effect of n-3 PUFAs on mental and retina disease in middle-aged and elderly
  669. Investigation of the Hydrolysis Characteristics for Increasing of PUFAs from Fish Oil by Lipolase-100T
  670. Influence of omega-3 PUFAs on the metabolism of proanthocyanidins in rats
  671. Metabolomic approach to the nutraceutical effect of rosemary extract plus omega-3 PUFAs in diabetic children with capillary electrophoresis.
  672. ω-3 PUFAs and Cachexia
  673. n-3 PUFAs and reperfusion injury in isolated cardiomyocytes
  674. A Single Mediterranean-Type Meal Leads to Postprandial Enrichment in Omega-3 PUFAs and Does Not Impair Flow-Mediated Dilatation in Comparison to a High …
  675. Effects of Different PUFAs Supplementation During the Postpartum Periods of Early Lactating Dairy Cows, I: Uterine Prostaglandin Synthesis.
  676. Factors influencing the effects of dietary supplementation with PUFAs on leukotriene generation by leucocytes in patients with asthma
  677. Efficiency of the use of polyunsaturated fatty acids (PUFAs) in treatment of cerebral atherosclerosis
  678. Effects of Different PUFAs Supplementation on Uterine Gene Expression During the Postpartum Periods of Early Lactating Dairy Cows.
  679. Study on antiadipogenic effects of omega n-3 polyunsaturated fatty acids (PUFAs) in vitro on adipocytes differentiated from bone marrow mesenchymal stem cells …
  680. Biosynthesis of C22-polyunsaturated fatty acids (PUFAs) in the moss physcomitrella patens by the algae paviova sp. 5-elongasa
  681. ω-3 PUFAs and Breast Cancer: Epidemiological Studies
  682. STUDIES O OPTIMIZATIO OF FERME TATIO PARAMETER FOR PUFAs PRODUCTIO
  683. Behavioral Resiliency of Mice to Repeated Mild Cerebral Concussion: Are there Interactions with Dietary Polyunsaturated Fatty Acids (PUFAs)?
  684. PUFAs mediate the COX-1 inflammatory pathway, a potential target for the treatment of epithelial ovarian cancer
  685. Children with autism: A pilot treatment trial with fishoil EPA/DHA. Evaluation of symptom change and changes in PUFAs after supplementation–a randomised double …
  686. Pulsed-Field Gel Analysis of Thraustochytrium aureum and Process for Targeting of Gene Involved in PUFAs Biosynthesis
  687. P0167 PP N-3 LC-PUFAs IN HUMAN COLOSTRUM MILK AND TH1/TH2-RELATED MRNA LEVELS IN CORD AND MATERNAL BLOOD
  688. Dynamic interactions between G proteins and plasma membrane nanodomains: Effects of antidepressants and PUFAs
  689. ω-3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases
  690. SUMMARY Macronutrient study for PUFAs production from tiie marine microalga Isochrysis galbana
  691. 1P-195 Effects of disruption of lipid rafts by PUFAs on T cell recognition (Biol & Artifi memb.: Signal transduction, The 47th Annual Meeting of the Biophysical Society of …

 

Related Posts

Shopping Cart
Scroll to Top